2007Pharmaceutical Care and ResearchRequires access

Pharmacokinetics and relative bioavailability of azithromycin tablets in healthy volunteers

HU Jin-hong

Open publisher page 0 citations

Abstract

Objective:To investigate the concentration-time profile and the relative bioavailability of test azithromycin tablets.Methods:A single oral dose of 500 mg azithromycin was given in a randomized,cross-over study in 20 healthy volunteers.Serum concentrations of azithromycin were determined by microbiological assay.Results:Concentration-time profile of the test tablet was well fitted to that of the reference tablets.The main pharmacokinetic parameters of the test and reference tablet were as follows:cmax(468.54±136.53) and(473.37±131.51) ng/mL,tmax(1.98±0.72) and(2.00±0.74) h,t1/2(39.35±8.08) and(41.23±7.94) h,AUC0~144(4 525.84±1 002.73) and(4 723.06±1 018.60) ng·h·mL-1.Conclusion:The results of statistical analysis showed that two formulations were bioequivalent.The relative bioavailability of test tablet is(96.27±10.22)%.

About this research paper

What this paper is about

Objective:To investigate the concentration-time profile and the relative bioavailability of test azithromycin tablets.Methods:A single oral dose of 500 mg azithromycin was given in a randomized,cross-over study in 20 healthy volunteers.Serum concentrations of azithromycin were determined by microbiological assay.Results:Concentration-time profile of the test tablet was well fitted to that of the reference tablets.The main pharmacokinetic parameters of the test and reference tablet were as follows:cmax(468.54±136.53) and(473.37±131.51) ng/mL,tmax(1.98±0.72) and(2.00±0.74) h,t1/2(39.35±8.08) and(41.23±7.94) h,AUC0~144(4 525.84±1 002.73) and(4 723.06±1 018.60) ng·h·mL-1.Conclusion:The results of statistical analysis showed that two formulations were bioequivalent.The relative bioavailability of test tablet is(96.27±10.22)%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the concentration-time profile and the relative bioavailability of test azithromycin tablets.Methods:A single oral dose of 500 mg azithromycin was given in a randomized,cross-over study in 20 healthy volunteers.Serum concentrations of azithromycin were determined by microbiological assay.Results:Concentration-time profile of the test tablet was well fitted to that of the reference tablets.The main pharmacokinetic parameters of the test and reference tablet were as follows:cmax(468.54±136.53) and(473.37±131.51) ng/mL,tmax(1.98±0.72) and(2.00±0.74) h,t1/2(39.35±8.08) and(41.23±7.94) h,AUC0~144(4 525.84±1 002.73) and(4 723.06±1 018.60) ng·h·mL-1.Conclusion:The results of statistical analysis showed that two formulations were bioequivalent.The relative bioavailability of test tablet is(96.27±10.22)%.

Key concepts: Bioequivalence, Bioavailability, Azithromycin, Cmax, Pharmacokinetics, Pharmacology, Medicine, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and relative bioavailability of azithromycin tablets in healthy volunteers — Research Paper | ScholarLens